Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,574 INR | -1.13% | -1.12% | -7.32% |
04-08 | Galaxy Surfactants Forms New Wholly-Owned Subsidiary | MT |
04-05 | Galaxy Surfactants Limited Announces Incorporation of Wholly Owned Subsidiary Company | CI |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The opinion of analysts covering the stock has improved over the past four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.19 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.32% | 1.11B | C+ | ||
+11.76% | 63.22B | A- | ||
-3.51% | 46.34B | A- | ||
+13.09% | 39.97B | B+ | ||
+17.83% | 25.46B | A- | ||
+8.37% | 18.68B | C+ | ||
+1.44% | 17.24B | B+ | ||
-20.33% | 15.81B | A- | ||
+0.36% | 14.9B | B+ | ||
-12.98% | 13.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GALAXYSURF Stock
- GALAXYSURF Stock
- Ratings Galaxy Surfactants Limited